StreetAlpha.app
Home › Stocks › MCK

Mckesson Corp (MCK)

Healthcare
$1091.70
▼ −1.21%
LAST CLOSE · NOV 17

McKesson distributes drugs and healthcare products to pharmacies and providers, and supplies medical products to clinics and care facilities. It last closed at $1091.70 on Nov 17, down 1.21% on the day. MCK reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 6 analysts is $1178.33 (+7.9% from the last close), with a high of $1255.00 and a low of $965.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in MCK, 0% of them bullish and 100% bearish. In the past 30 days there were 16 dark pool prints totaling $12.7M, the largest $1.9M.

AI Auto Pilots
Is MCK in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$419B
+8.2% vs a year ago
Net income
$4.7B
+16.5% vs a year ago
EPS (diluted)
$38.75
+21.1% vs a year ago
Free cash flow
$7.1B
1.7% margin
Valuation
Market cap
$126B
115.5M shares
P/E
28.2
Price over 12 month EPS
Price to sales
0.3
Market cap over revenue
Dividend yield
0.31%
$3.40 a share over 12 months
Balance sheet
Cash & equivalents
$6.5B
At Sep 30
Debt
$9.2B
At Sep 30
Shareholder equity
−$4.0B
Buybacks
$6.8B
Last 12 months
CEOBrian S. Tyler
Employees43,000 (Mar 31, 2026)
Fiscal year endsMarch
ExchangeNYSE
Financials history
FY2022: $264B$264BFY2022FY2023: $277B$277BFY2023FY2024: $309B$309BFY2024FY2025: $359B$359BFY2025FY2026: $403B$403BFY2026

From MCK's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$10.94
$114.02B revenue est.
Year-ago EPS
$9.34
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 6 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
6firms
5 Buy1 Hold0 Sell
Each firm's latest rating on MCK in the past 90 days
Average 12-month target
$1178.33
▲ 7.9% upside

Based on 6 analysts who set a price target on MCK in the past 90 days. The average target is $1178.33, with a high of $1255.00 and a low of $965.00, compared with the last close of $1091.70.

Low $965.00Avg $1178.33High $1255.00
Blue marker: last close $1091.70
Highest target$1255.00
Average target$1178.33
Lowest target$965.00
Latest rating changes
JP MorganMaintained
Nov 10Buy$1255
UBSTarget raised
Nov 6Buy$1200 → $1250
TD CowenTarget raised
Nov 5Buy$1006 → $1200
Leerink PartnersTarget raised
Nov 5Buy$1070 → $1200
RBC CapitalTarget raised
Nov 5Hold$845 → $965
DateFirmActionRatingPrice target
Nov 10JP MorganMaintainedBuy$1255
Nov 6UBSTarget raisedBuy$1200 → $1250
Nov 5TD CowenTarget raisedBuy$1006 → $1200
Nov 5Leerink PartnersTarget raisedBuy$1070 → $1200
Nov 5RBC CapitalTarget raisedHold$845 → $965
Loading…

Technical Analysis

MCK · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 5% above its 20 day and 12% above its 50 day average. It is 20% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 69), near overbought. The nearest support is the Pivot S1 at $1081.47, and the nearest resistance the Pivot at $1095.40.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 2.3%/day
Key levels
$1121.5052 week high+2.7%
$1121.50Swing high (Nov 5)+2.7%
$1105.63Pivot R1+1.3%
$1095.40Pivot+0.3%
$1091.70Last close
$1081.47Pivot S1−0.9%
$1036.2720 day average−5.1%
$963.1350 day average−11.8%
$954.05Swing low (Oct 28)−12.6%
$906.44100 day average−17.0%
$876.86200 day average−19.7%
$723.6852 week low−33.7%
Indicators
RSI (14)69.23Strong, overbought above 70Neutral
MACD38.68Above its signal lineBullish
Stochastic86.8Near the top of its rangeOverbought
ADX (14)36.6Trending up
Williams %R-19.0Oversold below −80, overbought above −20Overbought
CCI (20)92.0Oversold below −100, overbought above 100Neutral
Rate of change+9.2%Change over 10 sessionsBullish
ATR (14)$24.97Typical daily range, 2.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for MCK

What happened before

See how MCK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow MCK usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How MCK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Nov 16 – Nov 16
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
16
Notional
$12.7M
Largest print
$1.9M
Loading…

MCK Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●970 buying vs 846 selling
  • ▼Held by funds -5.9 pts
  • ▲Funds holding +46
  • ●Superinvestors: 3 added, 3 cut
  • ▼Put/call 0.46 to 0.60
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,0682,022+2.3%
In funds' top 103629+24.1%
Held by funds86.6%92.5%−5.9 pts
New / increased187 / 783141 / 706+14.5%
Reduced / sold out736 / 110798 / 183−13.8%
Put/call ratio0.600.46+29.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MCK institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MCK Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$6.8B
5.4% yield
Left in program
$4.3B
3.4% of value
Shares outstanding, 12 months
−6.5%
Fewer shares
Last quarter
$1.0B
Sep 2026
Avg price paid, last quarter
$867.47
1.2M shares bought
S&P 500 rank by spending
#32 of 358
 
Spent each quarter, last 3 yearsTop bar $2.7B
Dec 2023: $860.9M, average price $453.09Mar 2024: $2K, average price $270.20Jun 2024: $549.2M, average price $549.22Sep 2024: $1.5B, average price $529.15Dec 2024: $797.9M, average price $531.93Mar 2025: $302.4M, average price $604.87Jun 2025: $560.2M, average price $700.19Sep 2025: $824.3M, average price $686.96Dec 2025: $652.3M, average price $815.37Mar 2026: $2.3B, average price $930.99Jun 2026: $2.7B, average price $755.58Sep 2026: $1.0B, average price $867.47
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MCK is in one of them and how their past MCK trades turned out.

MCK in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MCK in an article yet. Here's the latest on the wider market.

MCK Congress Trades

All congress trades →
Trades, 12 months
27
Buys
19
70%
Sells
8
30%
People
11
Last filed Oct 7
Who traded MCK · since 2014
Latest 5 filings of 127
$1K – $15KTraded Sep 4, 2026Filed Oct 7, 2026
$1K – $15KTraded Aug 10, 2026Filed Sep 4, 2026
$1K – $15KTraded Jul 20, 2026Filed Aug 7, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded Jun 15, 2026Filed Jul 15, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KSep 4, 2026Oct 7, 202633 d
Ro KhannaD · CABuy$1K – $15KAug 10, 2026Sep 4, 202625 d
Ro KhannaD · CABuy$1K – $15KJul 20, 2026Aug 7, 202618 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Jonathan JacksonD · ILSell$1K – $15KJun 15, 2026Jul 15, 202630 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Mckesson

McKesson is a healthcare company based in Irving, Texas. It distributes prescription and over the counter drugs and other healthcare products to pharmacies, hospitals, and physicians in the United States and Canada. It also provides technology and services that help patients get their medicines and help biopharma companies reach patients. The company supplies medical products to physician offices, surgery centers, and nursing homes.

Headquarters
Irving, TX
Founded
1994